Innovating Works

Experimentica Ltd

Desconocido
NeoVasculoStop: NATURAL INTRAOCULAR PHOTOACTIVATION OF COMPOUNDS TO FIGHT RETINOPATHIES EXPERIMENTICA OY tramitó un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDEROPEN-01 Retinopathies constitute an extreme societal and socioeconomic burden that is expected to increase with an aging population and the increase...
2022-03-28 - 2026-02-28 | Financiado
CRYSTAL3: Commercial Research Opportunity for Cysteinyl Leukotriene Signalling in Ocular CNS Dysfunction... EXPERIMENTICA OY participó en un H2020: H2020-MSCA-RISE-2020 Cysteinyl leukotrienes (CysLTs) are potent lipid mediators of inflammation. CysLT1 and 2 receptors are widely expressed e.g. lungs, colorect...
2020-10-02 - 2024-12-31 | Financiado
ORBITAL: Ocular Research By Integrated Training And Learning Diseases of the posterior segment of the eye are increasing considerably, partly due to an ageing population (almost 20% of the population o...
2019-04-09 - 2024-02-29 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.